Pricing Log in Create free account

Entera Bio Ltd. (ENTX) vs Monopar Therapeutics Inc. (MNPR)

Entera Bio Ltd. and Monopar Therapeutics Inc. are both Biotechnology companies. Entera Bio Ltd. and Monopar Therapeutics Inc. are of similar size ($481.9M and $481.5M). Across the 8 metrics below, Monopar Therapeutics Inc. leads on 7 and Entera Bio Ltd. on 1.

Valuation

Metric ENTX MNPR Biotechnology median
P/E n/m n/m 8.50
P/S 606.32 n/m 9.71
P/B 18.61 4.52 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 541.12 n/m 9.21
Earnings yield (13.06%) (3.13%) (33.15%)
Free cash flow yield (8.13%) (2.06%) (25.50%)

Profitability

Metric ENTX MNPR Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (138.92%) (19.50%) (56.36%)
Return on assets (87.02%) (18.90%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ENTX MNPR Biotechnology median
Revenue growth (TTM) 66.42% — 6.02%
EPS growth (last fiscal year) 0.00% 54.99% 30.26%
Revenue growth, 5-year CAGR (29.19%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ENTX MNPR Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.98 33.56 4.72
Net debt to EBITDA 1.29 8.06 0.96

Dividend

Metric ENTX MNPR Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ENTX MNPR Biotechnology median
Market cap 481.53m 481.93m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack